WIDESPREAD INTRADERMAL ACCUMULATION OF MONONUCLEAR LEUKOCYTES IN LEPROMATOUS LEPROSY PATIENTS TREATED SYSTEMICALLY WITH RECOMBINANT INTERFERON-GAMMA

被引:28
|
作者
NATHAN, C
SQUIRES, K
GRIFFO, W
LEVIS, W
VARGHESE, M
JOB, CK
NUSRAT, AR
SHERWIN, S
RAPPOPORT, S
SANCHEZ, E
BURKHARDT, RA
KAPLAN, G
机构
[1] US PHS,BAYLEY SETON HOSP,HANSENS DIS CTR,STATEN ISL,NY 10304
[2] ROCKEFELLER UNIV,CELLULAR PHYSIOL & IMMUNOL LAB,NEW YORK,NY 10021
[3] GENENTECH INC,S SAN FRANCISCO,CA 94080
[4] CORNELL UNIV,MED CTR,DEPT MED,DIV DERMATOL,NEW YORK,NY 10021
[5] CORNELL UNIV,MED CTR,DEPT MED,DIV INFECT DIS,NEW YORK,NY 10021
[6] CORNELL UNIV,MED CTR,DEPT MED,DIV DERMATOL,NEW YORK,NY 10021
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1990年 / 172卷 / 05期
关键词
D O I
10.1084/jem.172.5.1509
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Intradermal administration ofrecombinant interferon γ(rIFN-γ) to lepromatous leprosy patients has converted the local histology toward a tuberculoid pattern. However, such changes have been confined to the site of injection. In contrast, in the present study, marked, intradermal accumulation of CD3+, CD4+, CD8+, and CD1a+ T cells and Leu-M5+ mononuclear phagocytes was induced at a distance from the sites of administration, in a dose-dependent manner, by 10 daily intramuscular injections of 10-30 μg rIFN-γ/m2. Mononuclear cell infiltration began within 3 d of onset of rIFN-γ therapy and persisted at least 8 wk. Intramuscular administration of rIFN-γ to lepromatous patients receiving concurrent chemotherapy can safely induce widespread histologic features of an upgrading reaction. © 1990, Rockefeller University Press., All rights reserved.
引用
收藏
页码:1509 / 1512
页数:4
相关论文
共 50 条
  • [21] HEMOLYTIC-ANEMIA IN A CANCER-PATIENT TREATED WITH RECOMBINANT INTERFERON-GAMMA
    RABINOWITZ, AP
    HU, E
    WATKINS, K
    MAZUMDER, A
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1990, 9 (02): : 256 - 259
  • [22] CHARACTERIZATION OF THE INTERACTION BETWEEN RECOMBINANT HUMAN INTERFERON-GAMMA AND ITS RECEPTOR ON HUMAN POLYMORPHONUCLEAR LEUKOCYTES
    HANSEN, BD
    FINBLOOM, DS
    JOURNAL OF LEUKOCYTE BIOLOGY, 1990, 47 (01) : 64 - 69
  • [23] INDUCTION OF TAC ANTIGEN AND FC-GAMMA RECEPTORS ON HUMAN MONONUCLEAR-CELLS BY RECOMBINANT INTERFERON-GAMMA
    ARITA, Y
    DOI, S
    TANABE, S
    NISHIKORI, M
    UCHINO, H
    EXPERIMENTAL HEMATOLOGY, 1987, 15 (05) : 481 - 481
  • [24] RECOMBINANT INTERLEUKIN-4 SUPPRESSES THE PRODUCTION OF INTERFERON-GAMMA BY HUMAN MONONUCLEAR-CELLS
    PELEMAN, R
    WU, J
    FARGEAS, C
    DELESPESSE, G
    JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (05): : 1751 - 1756
  • [25] THE ABSENCE OF INTERFERON ANTIBODY-FORMATION IN PATIENTS RECEIVING RECOMBINANT HUMAN INTERFERON-GAMMA
    JAFFE, HS
    CHEN, AB
    KRAMER, S
    SHERWIN, SA
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1987, 6 (06): : 576 - 580
  • [26] THE USE OF RECOMBINANT HUMAN INTERFERON-GAMMA IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    SEITZ, M
    FRANKE, M
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 1986, 45 (04): : 224 - 225
  • [27] Eosinophilic pustular folliculitis effectively treated with recombinant interferon-gamma: Suppression of mRNA expression of interleukin 5 in peripheral blood mononuclear cells
    Fushimi, M
    Tokura, Y
    Sachi, Y
    Hashizume, H
    Sudo, H
    Wakita, H
    Furukawa, F
    Takigawa, M
    BRITISH JOURNAL OF DERMATOLOGY, 1996, 134 (04) : 766 - 772
  • [28] INTERFERON-GAMMA PRODUCTION BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS AND INTERFERON-GAMMA ACTIVITY IN SERA OF PATIENTS WITH CHRONIC LIVER-DISEASE
    KAKUMU, S
    HAYASHI, H
    YAGI, A
    FUJI, A
    SAKAMOTO, N
    KIDOKORO, R
    AOI, T
    HEPATOLOGY, 1986, 6 (04) : 798 - 798
  • [29] AUTOLOGOUS TRANSPLANTATION FOR CML USING MARROW TREATED EXVIVO WITH RECOMBINANT HUMAN INTERFERON-GAMMA
    MCGLAVE, PB
    ARTHUR, D
    MILLER, WJ
    LASKY, L
    KERSEY, J
    BONE MARROW TRANSPLANTATION, 1990, 6 (02) : 115 - 120
  • [30] THE RESPONSE OF FXIIIA AND MAC-387 POSITIVE MONONUCLEAR-CELLS TO RECOMBINANT INTERFERON-GAMMA INVIVO
    SPAULL, J
    CERIO, R
    BARKER, J
    MACDONALD, DM
    WILSON, JE
    CLINICAL RESEARCH, 1989, 37 (02): : A654 - A654